Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37

► The proper hydrophobicity of antimicrobial peptides is crucial to exert the amalgamated property of LPS-neutralizing activity and prokaryotic selectivity. ► Analog a4-W2 showed more improved prokaryotic selectivity compared to LL-37. ► Analog a4-W2 displayed LPS-neutralizing activity comparable to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Peptides (New York, N.Y. : 1980) N.Y. : 1980), 2012-06, Vol.35 (2), p.239-247
Hauptverfasser: Nan, Yong Hai, Bang, Jeong-Kyu, Jacob, Binu, Park, Il-Seon, Shin, Song Yub
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:► The proper hydrophobicity of antimicrobial peptides is crucial to exert the amalgamated property of LPS-neutralizing activity and prokaryotic selectivity. ► Analog a4-W2 showed more improved prokaryotic selectivity compared to LL-37. ► Analog a4-W2 displayed LPS-neutralizing activity comparable to that of LL-37. ► The effective site of Trp-substitution for high LPS-neutralizing activity of α-helical antimicrobial peptides is the amphipathic interface in the α-helical wheel projection. To develop novel antimicrobial peptides (AMPs) with shorter lengths, improved prokaryotic selectivity and retained lipolysaccharide (LPS)-neutralizing activity compared to human cathelicidin AMP, LL-37, a series of amino acid-substituted analogs based on IG-19 (residues 13–31 of LL-37) were synthesized. Among the IG-19 analogs, the analog a4 showed the highest prokaryotic selectivity, but much lower LPS-neutralizing activity compared to parental LL-37. The analogs, a5, a6, a7 and a8 with higher hydrophobicity displayed LPS-neutralizing activity comparable to that of LL-37, but much lesser prokaryotic selectivity. These results indicate that the proper hydrophobicity of the peptides is crucial to exert the amalgamated property of LPS-neutralizing activity and prokaryotic selectivity. Furthermore, to increase LPS-neutralizing activity of the analog a4 without a remarkable decrease in prokaryotic selectivity, we synthesized Trp-substituted analogs (a4-W1 and a4-W2), in which Phe5 or Phe15 of a4 is replaced by Trp. Despite their same prokaryotic selectivity, a4-W2 displayed much higher LPS-neutralizing activity compared to a4-W1. When compared with parental LL-37, a4-W2 showed retained LPS-neutralizing activity and 2.8-fold enhanced prokaryotic selectivity. These results suggest that the effective site for Trp-substitution when designing novel AMPs with higher LPS-neutralizing activity, without a remarkable reduction in prokaryotic selectivity, is the amphipathic interface between the end of the hydrophilic side and the start of the hydrophobic side rather than the central position of the hydrophobic side in their α-helical wheel projection. Taken together, the analog a4-W2 can serve as a promising template for the development of therapeutic agents for the treatment of endotoxic shock and bacterial infection.
ISSN:0196-9781
1873-5169
DOI:10.1016/j.peptides.2012.04.004